First Time Loading...

Beijing Scitop Bio-tech Co Ltd
SZSE:300858

Watchlist Manager
Beijing Scitop Bio-tech Co Ltd Logo
Beijing Scitop Bio-tech Co Ltd
SZSE:300858
Watchlist
Price: 15.55 CNY 0.78% Market Closed
Updated: Apr 28, 2024
Section:
 

Wall Street
Price Targets

Price Targets Summary
Beijing Scitop Bio-tech Co Ltd

Wall Street analysts forecast Beijing Scitop Bio-tech Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Beijing Scitop Bio-tech Co Ltd is 18.02 CNY with a low forecast of 17.85 CNY and a high forecast of 18.55 CNY.

Lowest Forecast
Wall Street Target
17.85 CNY
15% Upside
Average Forecast
Wall Street Target
18.02 CNY
16% Upside
Highest Forecast
Wall Street Target
18.55 CNY
19% Upside
Lowest
Price Target
17.85 CNY
15% Upside
Average
Price Target
18.02 CNY
16% Upside
Highest
Price Target
18.55 CNY
19% Upside
Beijing Scitop Bio-tech Co Ltd Competitors:
Price Targets
B
002696
Baiyang Investment Group Inc
202% Upside
1216
Uni-President Enterprises Corp
1% Downside
TSN
Tyson Foods Inc
2% Upside
BRITANNIA
Britannia Industries Ltd
13% Upside
B
002696
Baiyang Investment Group Inc
202% Upside
1216
Uni-President Enterprises Corp
1% Downside
TSN
Tyson Foods Inc
2% Upside
BRITANNIA
Britannia Industries Ltd
13% Upside
600467
Shandong Homey Aquatic Development Co Ltd
158% Upside
G
603886
Ganso Co Ltd
35% Upside
KRBL
KRBL Ltd
52% Upside
002982
Hunan Xiangjia Animal Husbandry Co Ltd
84% Upside

Revenue
Forecast

Revenue Estimate
Beijing Scitop Bio-tech Co Ltd

For the last 4 years the compound annual growth rate for Beijing Scitop Bio-tech Co Ltd's revenue is 4%. The projected CAGR for the next 3 years is 24%.

4%
Past Growth
24%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Beijing Scitop Bio-tech Co Ltd

For the last 4 years the compound annual growth rate for Beijing Scitop Bio-tech Co Ltd's operating income is 2%. The projected CAGR for the next 3 years is 15%.

2%
Past Growth
15%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Beijing Scitop Bio-tech Co Ltd

For the last 4 years the compound annual growth rate for Beijing Scitop Bio-tech Co Ltd's net income is 5%. The projected CAGR for the next 3 years is 27%.

5%
Past Growth
27%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Beijing Scitop Bio-tech Co Ltd's stock price target?
Price Target
18.02 CNY

According to Wall Street analysts, the average 1-year price target for Beijing Scitop Bio-tech Co Ltd is 18.02 CNY with a low forecast of 17.85 CNY and a high forecast of 18.55 CNY.

What is Beijing Scitop Bio-tech Co Ltd's Revenue forecast?
Projected CAGR
24%

For the last 4 years the compound annual growth rate for Beijing Scitop Bio-tech Co Ltd's revenue is 4%. The projected CAGR for the next 3 years is 24%.

What is Beijing Scitop Bio-tech Co Ltd's Operating Income forecast?
Projected CAGR
15%

For the last 4 years the compound annual growth rate for Beijing Scitop Bio-tech Co Ltd's operating income is 2%. The projected CAGR for the next 3 years is 15%.

What is Beijing Scitop Bio-tech Co Ltd's Net Income forecast?
Projected CAGR
27%

For the last 4 years the compound annual growth rate for Beijing Scitop Bio-tech Co Ltd's net income is 5%. The projected CAGR for the next 3 years is 27%.

ALPHA SPREAD
Join more than 132,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.